27-Jan-2026 3:10 AM CST - Seeking Alpha IBB: Beyond The 2025 Surge, Biotech Breakout Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
26-Jan-2026 4:22 AM CST - Seeking Alpha IBB: Biotech's Hot Streak May Cool IBB ETF analysis: hold rating as biotech consolidates near highs. Fair 19x P/E, low EPS growth and weak seasonality shape risk/reward.
9-Jan-2026 11:50 AM CST - Yahoo Finance Here's Why Biotech ETFs Are Rallying Hard Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.
23-Dec-2025 12:03 PM CST - The Motley Fool IBIT vs. ETHA: How Bitcoin and Ethereum Shape Crypto ETF Risk Both funds offer regulated crypto exposure, but bitcoin and ethereum behave differently in volatility and capital flows, shaping how each ETF fits inside a portfolio
20-Dec-2025 1:00 PM CST - The Motley Fool 3 Best Bitcoin ETF Picks for 2026 Bitcoin experienced a lot of volatility in 2025 without much in the way of total return. How is 2026 shaping up for Bitcoin ETFs?
19-Dec-2025 11:05 PM CST - The Motley Fool Janus Henderson B-BBB CLO ETF (JBBB): How to Buy The Janus Henderson B-BBB CLO ETF (JBBB) offers a yield pick-up versus AAA CLOs, but comes with higher credit risk and volatility.
17-Dec-2025 1:35 PM CST - Seeking Alpha Why PPH Keeps Working When Single Themes Break VanEck Pharmaceutical ETF is rated a Buy with stability, earnings visibility, and resilience across volatile market cycles. Read more on PPH ETF here.
12-Dec-2025 9:34 AM CST - The Motley Fool 3 High-Powered ETFs That Have Doubled in Value in Just 3 Years However, focusing on tech hasn't been bad at all for investors. In three years, the Invesco fund has risen by 123%, which is far better than the S&P 500 's gains of just 75% over that same time frame. As long as you're comfortable with the added volatility that can come with tech stocks, this can be a great fund to hang on to for the long haul.
27-Jan-2026 3:10 AM CST - Seeking Alpha IBB: Beyond The 2025 Surge, Biotech Breakout Shares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
26-Jan-2026 4:22 AM CST - Seeking Alpha IBB: Biotech's Hot Streak May Cool IBB ETF analysis: hold rating as biotech consolidates near highs. Fair 19x P/E, low EPS growth and weak seasonality shape risk/reward.
9-Jan-2026 11:50 AM CST - Yahoo Finance Here's Why Biotech ETFs Are Rallying Hard Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.
23-Dec-2025 12:03 PM CST - The Motley Fool IBIT vs. ETHA: How Bitcoin and Ethereum Shape Crypto ETF Risk Both funds offer regulated crypto exposure, but bitcoin and ethereum behave differently in volatility and capital flows, shaping how each ETF fits inside a portfolio
20-Dec-2025 1:00 PM CST - The Motley Fool 3 Best Bitcoin ETF Picks for 2026 Bitcoin experienced a lot of volatility in 2025 without much in the way of total return. How is 2026 shaping up for Bitcoin ETFs?
19-Dec-2025 11:05 PM CST - The Motley Fool Janus Henderson B-BBB CLO ETF (JBBB): How to Buy The Janus Henderson B-BBB CLO ETF (JBBB) offers a yield pick-up versus AAA CLOs, but comes with higher credit risk and volatility.
17-Dec-2025 1:35 PM CST - Seeking Alpha Why PPH Keeps Working When Single Themes Break VanEck Pharmaceutical ETF is rated a Buy with stability, earnings visibility, and resilience across volatile market cycles. Read more on PPH ETF here.
12-Dec-2025 9:34 AM CST - The Motley Fool 3 High-Powered ETFs That Have Doubled in Value in Just 3 Years However, focusing on tech hasn't been bad at all for investors. In three years, the Invesco fund has risen by 123%, which is far better than the S&P 500 's gains of just 75% over that same time frame. As long as you're comfortable with the added volatility that can come with tech stocks, this can be a great fund to hang on to for the long haul.
